Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut ...

There are different approaches to the treatment of children with chronic hepatitis C. [42] The main characteristic of chronic hepatitis C is its persistence over time with slow progression to ...

Available therapies have no contraindication in children if otherwise healthy. The US FDA and EMEA have recently approved combined pegylated-IFN-α2b plus ribavirin treatment for children ...

22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults ... and misuse. "Treatment-resistant depression can be very ...

22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder ... respiratory depression, ...

nasal spray bottle WEDNESDAY ... respiratory depression, abuse, and misuse. "Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...

The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone ... is now the first-ever standalone therapy for treatment-resistant depression, which is when trying ...

Enlarged adenoids or nasal polyps. Functional causes: • Weakness or paralysis of the muscles of the soft palate. • Neurological disorders, such as cerebral palsy or Moebius syndrome. • The voice ...